Search Results - "Jauffret-Roustide, M"

This result is not displayed to guests.
Login for full access.

Impact of drug consumption rooms on non-fatal overdoses, abscesses and emergency department visits in people who inject drugs in France: results from the COSINUS cohort.

Authors: Roux, P Jauffret-Roustide, M Donadille, C et al.

Source: International Journal of Epidemiology. Apr2023, Vol. 52 Issue 2, p562-576. 15p.

Impact of a Harm-Reduction Policy on HIV and Hepatitis C Virus Transmission Among Drug Users: Recent French Data—The ANRS-Coquelicot Study.

Authors: Jauffret-Roustide, M. Emmanuelli, J. Quaglia, M. et al.

Source: Substance Use & Misuse. 2006, Vol. 41 Issue 10-12, p1603-1621. 19p. 2 Charts, 1 Graph.

Subjects: AIDS prevention, Harm reduction, Risk management in business, HIV, Hepatitis viruses, HIV infections, Liver diseases, Hepatitis C virus, Viral hepatitis, Flaviviruses, Lentivirus diseases

How far are we? Assessing progress in hepatitis C response towards the WHO 2030 elimination goals by the civil society monitoring in 25 European countries, period 2020 to 2023.

Authors: Maticic, Mojca Cernosa, J. Loboda, C. et al.

Source: Harm Reduction Journal. 11/20/2024, Vol. 21 Issue 1, p1-18. 18p.

P.442 HCV and HIV seroprevalences and at-risk behaviors among drug users, ANRS-Coquelicot study, France, 2004

Authors: Jauffret-Roustide, M. Couturier, E. Barin, F. et al.

Source: Journal of Clinical Virology. Jul2006 Supplement 2, Vol. 36 Issue s2, pS197-S198. 0p.

Migration experiences, life conditions, and drug use practices of Russian-speaking drug users who live in Paris: a mixed-method analysis from the ANRS-Coquelicot study.

Authors: Tibi-Lévy, Yaël Serebryakova, Daria Jauffret-Roustide, Marie et al.

Source: Harm Reduction Journal. 8/10/2020, Vol. 17 Issue 1, p1-16. 16p. 6 Charts.

Effectiveness and cost‐effectiveness of interventions targeting harm reduction and chronic hepatitis C cascade of care in people who inject drugs: The case of France.

Authors: Cousien, A. Tran, V. C. Deuffic‐Burban, S. et al.

Source: Journal of Viral Hepatitis. Oct2018, Vol. 25 Issue 10, p1197-1207. 11p.

Dynamic modelling of hepatitis C virus transmission among people who inject drugs: a methodological review.

Authors: Cousien, A. Tran, V. C. Deuffic‐Burban, S. et al.

Source: Journal of Viral Hepatitis. Mar2015, Vol. 22 Issue 3, p213-229. 17p.

Estimating prevalence from dried blood spots without using biological cut-offs: application of a novel approach to hepatitis C virus in drug users in France (ANRS-Coquelicot survey).

Authors: Léon, L Pillonel, J Jauffret-Roustide, M et al.

Source: Epidemiology & Infection. Jan2019, Vol. 147, pe220-e220. 1p.

The civil society monitoring of hepatitis C response related to the WHO 2030 elimination goals in 35 European countries.

Authors: Maticic, M. Pirnat, Z. Leicht, A. et al.

Source: Harm Reduction Journal. 11/19/2020, Vol. 17 Issue 1, pN.PAG-N.PAG. 1p.

Restrictions on access to direct-acting antivirals for people who inject drugs: The European Hep-CORE study and the role of patient groups in monitoring national HCV responses.

Authors: Lazarus, J.V. Safreed-Harmon, K. Stumo, S.R. et al.

Source: International Journal of Drug Policy. Sep2017, Vol. 47, p47-50. 4p.

Hepatitis B virus in drug users in France: prevalence and vaccination history, ANRS-Coquelicot Survey 2011-2013.

Authors: BROUARD, C. PILLONEL, J. SOGNI, P. et al.

Source: Epidemiology & Infection. Apr2017, Vol. 145 Issue 6, p1259-1269. 11p.

Age- and time-dependent prevalence and incidence of hepatitis C virus infection in drug users in France, 2004-2011: model-based estimation from two national cross-sectional serosurveys.

Authors: LEON, L. KASEREKA, S. BARIN, F. et al.

Source: Epidemiology & Infection. Apr2017, Vol. 145 Issue 5, p895-907. 13p.

Étude sociologique sur le contexte et les perceptions du don chez les donneurs trouvés positifs pour le VIH en France entre 2011 et 2014.

Authors: Santos, A. Pillonel, J. Jauffret-Roustide, M.

Source: Transfusion Clinique et Biologique. Sep2015, Vol. 22 Issue 4, p211-211. 1p.

O89 IMPACT OF NEW DAA-CONTAINING REGIMENS ON HCV TRANSMISSION AMONG INJECTING DRUG USERS (IDUS): A MODEL-BASED ANALYSIS (ANRS 12376).

Authors: Cousien, A. Tran, V.C. Jauffret-Roustide, M. et al.

Source: Journal of Hepatology. Apr2014 Supplement, Vol. 60, pS36-S37. 1p.

Grippe saisonnière, grippe aviaire, grippe pandémique : connaissances et attitudes

Alternate Title: Seasonal influenza, avian influenza, pandemic influenza: knowledge and behavior

Authors: Gautier, A. Jestin, C. Jauffret-Roustide, M.

Source: Medecine & Maladies Infectieuses. Jun2008 Supplement 2, Vol. 38, pS71-S73. 0p.

Mandatory immunization: The point of view of the French general population and practitioners

Authors: Nicolay, N. Lévy-Bruhl, D. Gautier, A. et al.

Source: Vaccine. Oct2008, Vol. 26 Issue 43, p5484-5493. 10p.

Do DSM-5 substance use disorder criteria differ by user care settings? An item response theory analysis approach.

Authors: Kervran, C. Shmulewitz, D. Serre, F. et al.

Source: Addictive Behaviors. May2021, Vol. 116, pN.PAG-N.PAG. 1p.

Subject Terms: *Item response theory, *Research, *Research methodology, *Evaluation research, *Comparative studies, *Cocaine, Substance abuse, Structural equation modeling, Discrimination in medical care, Diagnosis, Psychometrics, Substance abuse diagnosis, Desire, Medical cooperation, Classification of mental disorders, Drug abusers

Prévalence des infections par les virus des hépatites C (VHC) et B (VHB) et couverture vaccinale contre le VHB chez les hommes ayant des relations sexuelles avec des hommes fréquentant des lieux de convivialité gay de cinq villes françaises

Authors: Vaux, S. Chevaliez, S. Saboni, L. et al.

Source: Medecine & Maladies Infectieuses. Jun2018:Supplement, Vol. 48, pS29-S29. 1p.

Les risques infectieux alimentaires et les zoonoses vus par les Français et leur médecin

Alternate Title: Risk of foodborne and zoonotic diseases as perceived by French citizens and their physicians

Authors: Capek, I. Jourdan-Da Silva, N. Gautier, A. et al.

Source: Medecine & Maladies Infectieuses. Jun2008 Supplement 2, Vol. 38, pS74-S77. 0p.